Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|December 5, 1993
Signaling-defective mutants of the B lymphocyte antigen receptor fail to associate with Ig-alpha and Ig-beta/gammaS A Grupp, K Campbell, R N Mitchell, et al.
Bone Marrow Transplantation|January 20, 2004
An unexpectedly high incidence of Epstein-Barr virus lymphoproliferative disease after CD34+ selected autologous peripheral blood stem cell transplant in neuroblastomaJ L Powell, N J Bunin, C Callahan, et al.
The Journal of Experimental Medicine|January 1, 1995
Molecular mechanisms that control expression of the B lymphocyte antigen receptor complexS A Grupp, R N Mitchell, K L Schreiber, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1995
The ligand-induced membrane IgM association with the cytoskeletal matrix of B cells is not mediated through the Ig alpha beta heterodimerJ H Hartwig, L S Jugloff, N J De Groot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2001
Angiogenesis inhibitor TNP-470 during bone marrow transplant: safety in a preclinical modelJ W Stern, J Fang, S Shusterman, et al.
Medical and Pediatric Oncology|December 7, 2000
Rapid-sequence tandem transplant for children with high-risk neuroblastomaS A Grupp, J W Stern, N Bunin, et al.
The Journal of Experimental Medicine|May 1, 1995
Intracellular targeting of antigens internalized by membrane immunoglobulin in B lymphocytesR N Mitchell, K A Barnes, S A Grupp, et al.
Blood Cancer Journal|June 4, 2016
Improved anti-leukemia activities of adoptively transferred T cells expressing bispecific T-cell engager in miceX Liu, D M Barrett, S Jiang, et al.
Medical and Pediatric Oncology|December 7, 2000
CD34 selection as a stem cell purging strategy for neuroblastoma: preclinical and clinical studiesJ Donovan, J Temel, A Zuckerman, et al.
Bone Marrow Transplantation|May 10, 2016
Toxicities of busulfan/melphalan versus carboplatin/etoposide/melphalan for high-dose chemotherapy with stem cell rescue for high-risk neuroblastomaA V Desai, M B Heneghan, Y Li, et al.
Pageof 4